SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBridgepoint Regulatory News (BPT)

Share Price Information for Bridgepoint (BPT)

Share Price is delayed by 15 minutes
Get Live Data
244.40    5.60 (2.35%)
Bid:
244.60
Ask:
245.00
Spread: 0.40 (0.164%)
Market Cap: £2.14b
BPT Live PriceLast checked at - London Stock Exchange

Intraday Bridgepoint Share Chart

Statement regarding Press Speculation

28 Nov 2022 18:01

RNS Number : 8420H
Bridgepoint Group plc
28 November 2022
Β 

28 November 2022

Bridgepoint Group plc

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

Statement regarding press speculation

Bridgepoint Group plc ("Bridgepoint" or the "Company") notes the recent media speculation regarding possible M&A. The Company confirms it is evaluating a number of potential strategic opportunities in line with its stated strategy and as confirmed in its recent trading update. All such discussions, including those held with Energy Capital Partners, remain at an early stage and there is no certainty that any transaction will result.

Further announcements will be made if appropriate.

Β 

-ENDS-

Β 

Enquiries

Bridgepoint

Β 

Analysts and investors

Adam Key

adam.key@bridgepoint.eu

+44 7833 748010

Β 

Media

Christian Jones / James Murray

Christian.jones@bridgepoint.eu

James.murray@bridgepoint.eu

+44 20 7034 3500

Β 

Β 

Finsbury Glover Hering (Public Relations Adviser to Bridgepoint)

Β 

Charles O'Brien

Β +44Β 20Β 7251Β 3801 / +44Β 7825Β 043656

Anjali Unnikrishnan

Β +44Β 20Β 7251Β 3801 / +44Β 7826Β 534233

Bridgepoint@Finsbury.comΒ 

Β 

Β 

Β 

The person responsible for this announcement on behalf of the Company is Rachel Thompson, Group General Counsel of Bridgepoint.

This announcement has been prepared for the purpose of complying with the applicable law and regulation of the United Kingdom and information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of jurisdictions outside the United Kingdom.

This announcement may include statements that are, or may be deemed to be, forward-looking statements. These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "envisages", "plans", "projects", "anticipates", "targets", "aims", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results or outcomes. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other uncertainties and assumptions. Forward-looking statements speak only as of the date they are made and cannot be relied upon. Save as required by law or regulation, the Company disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect events or circumstances after the date of this announcement.

None of the contents of the Company's website, nor of any other website, is incorporated in, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
SPCFLFEDLALTFIF
Date   Source Headline
1st Mar 20237:00 amRNSTransaction in Own Shares
28th Feb 20237:00 amRNSTransaction in Own Shares
27th Feb 20237:00 amRNSTransaction in Own Shares
24th Feb 20237:00 amRNSTransaction in Own Shares
23rd Feb 20237:00 amRNSTransaction in Own Shares
22nd Feb 20237:00 amRNSTransaction in Own Shares
21st Feb 20237:00 amRNSTransaction in Own Shares
20th Feb 20237:00 amRNSTransaction in Own Shares
17th Feb 20237:00 amRNSTransaction in Own Shares
16th Feb 20237:00 amRNSTransaction in Own Shares
15th Feb 20237:00 amRNSTransaction in Own Shares
14th Feb 20237:00 amRNSTransaction in Own Shares
13th Feb 20237:00 amRNSTransaction in Own Shares
10th Feb 20237:00 amRNSTransaction in Own Shares
9th Feb 20237:00 amRNSTransaction in Own Shares
8th Feb 20237:00 amRNSTransaction in Own Shares
7th Feb 20237:00 amRNSTransaction in Own Shares
6th Feb 20237:00 amRNSTransaction in Own Shares
3rd Feb 20237:00 amRNSTransaction in Own Shares
2nd Feb 20233:00 pmRNSFormation of ESG Committee
2nd Feb 20237:00 amRNSTransaction in Own Shares
1st Feb 20237:00 amRNSTotal Voting Rights
1st Feb 20237:00 amRNSTransaction in Own Shares
31st Jan 20237:00 amRNSTransaction in Own Shares
30th Jan 20237:00 amRNSTransaction in Own Shares
27th Jan 20237:00 amRNSTransaction in Own Shares
26th Jan 20237:00 amRNSTransaction in Own Shares
25th Jan 20237:00 amRNSTransaction in Own Shares
24th Jan 20237:00 amRNSShare Buyback Programme
22nd Dec 20227:00 amRNSHolding(s) in Company
28th Nov 20226:01 pmRNSStatement regarding Press Speculation
23rd Nov 20227:00 amRNSDirectorate Change
16th Nov 20227:00 amRNSTrading Statement
23rd Sep 202210:10 amRNSDirector/PDMR Shareholding
12th Sep 20223:11 pmRNSChange of Registered Office
5th Aug 20227:00 amRNSDirector/PDMR Shareholding
26th Jul 20227:00 amRNSHalf-year Report
13th May 20227:00 amRNSResult of AGM
6th Apr 20227:00 amRNSHolding(s) in Company
1st Apr 20223:00 pmRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSAnnual Report and Accounts and Notice of AGM
24th Mar 20227:00 amRNSPreliminary Results
22nd Mar 20223:00 pmRNSDirector Declaration
16th Dec 20218:56 amRNSDirector Declaration
16th Nov 20217:00 amRNSQuarterly Trading Update
21st Sep 20219:57 amRNSHolding(s) in Company
15th Sep 20217:00 amRNSHalf-Year Update 2021
28th Jul 20214:42 pmRNSHolding(s) in Company
26th Jul 202110:15 amRNSHolding(s) in Company
26th Jul 20218:10 amRNSAdmission to Trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.